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Introduction: Epicardial potentials (EP) derived from the body surface potential map (BSPM) improve acute myocardial infarction (AMI) diagnosis. In this study, we compared EP derived from the 80-lead BSPM using a standard thoracic volume conductor model (TVCM) with those derived using a patient-specific torso model (PSTM) based on body mass index (BMI).
Methods: Consecutive patients presenting to both the ED and pre-hospital coronary care unit between August 2009 and August 2011 with acute ischaemic-type chest pain at rest were enrolled. At first medical contact, 12-lead ECG and BSPM were recorded. BMI for each patient was calculated. Cardiac troponin-T (cTnT) was sampled 12h after symptom onset. Patients were excluded from analysis if they had any electrocardiographic confounders to interpretation of the ST-segment. A cardiologist assessed the 12-lead ECG for STEMI by Minnesota criteria and the BSPM. BSPM ST-elevation (STE) was ≥0.2mV in anterior, ≥0.1mV in lateral, inferior, RV or high right anterior and ≥0.05mV in posterior territories. To derive EP, the BSPM data were interpolated to yield values at 352-nodes of a Dalhousie torso. Using an inverse solution based on the boundary element method, EP at 98 cardiac nodes positioned within a standard TVCM were derived. The TVCM was then scaled to produce a PSTM, using a model developed from computed tomography (CT) in 48 patients of varying BMI, and EP re-calculated. EP >0.3mV defined STE. A cardiologist blinded to both the 12-lead ECG and BSPM interpreted the EP map. AMI was defined as cTnT ≥0.1µg/L.
Results: Enrolled were 400 patients (age 62 ± 13 yrs; 57% male): 80 patients had exclusion criteria. Of the remaining 320 patients, BMI was 27.8  5.6kg m-2. Of these, 180 (56%) had AMI. Overall, 132 had Minnesota STE on ECG (sensitivity 65%, specificity 89%) and 160 had BSPM STE (sensitivity 81%, specificity 90%). EP STE occurred in 165 patients using TVCM (sensitivity 88%, specificity 95%, p<0.001) and in 206 patients using PSTM (sensitivity 98%, specificity 79%, p<0.001). Of those with AMI by cTnT and EP ≤0.3mV using TVCM (n=22), 18 (82%) patients had EP >0.3mV when an individualised PSTM was used. 







In ACS patients, prompt diagnosis of acute coronary occlusion with early reperfusion therapy leads to a reduction in morbidity and mortality. However, initial 12-lead (12L) ECG has limited sensitivity (50-60%) for STEMI diagnosis [1] with over 20% of patients categorised as Non-STEMI on 12L ECG having an occluded artery in the early infarct setting [2]. Undiagnosed STEMI represents a high-risk patient group: at least 12.2% suffer death or non-fatal AMI at 6-months [3]. As such, rapid determination of an occluded coronary artery at presentation is paramount. 

BSPM ST-segment elevation (STE) improves sensitivity (76%) for AMI diagnosis over 12L ECG while retaining similar specificity (92%) [4]. Furthermore, in patients with chest pain and ST-segment depression only on initial 12L ECG, BSPM STE has sensitivity 91% and specificity 72% for AMI and acute coronary occlusion on angiography [5]. In the OCCULT-MI trial, a large prospective multicentre study, it was shown that BSPM increased STEMI diagnosis by 27.5% over the standard 12L ECG [6]. In addition, patients in whom STE was only detected on BSPM had increased risk (OR 3.4) of death and recurrent AMI at 30-days post-presentation [6] due to a delayed revascularisation strategy.

Epicardial Potentials (EPs) derived from Body Surface Potentials, a process known as inverse electrocardiography, further improves AMI diagnosis by removing the effect of the thoracic volume on electrical conduction [7]. However, to date the method used to derive EPs assumes that all patients have torso geometry similar to an athletic, adult male. In an increasingly obese population, individualised inverse electrocardiography has the potential to further improve AMI diagnosis, since an individualised torso geometry has shown potential in deriving more accurate EPs than those calculated using an undiscriminating male standard [8-10]. 








Review of a hospital database of patients undergoing PET-CT scanning as part of their clinical care was undertaken (n=5450). Within each quartile (Q1 [BMI ≤ 20.0 kg/m2]; Q2 [BMI 20.1 - 30.0 kg/m2]; Q3 [BMI 30.1 - 40.0 kg/m2]; and Q4 [BMI > 40.0 kg/m2]), 12 patients were randomly selected (50% male) for analysis (n total = 48).






Between August 2009 and August 2011 we studied all patients admitted to our coronary care unit using either the emergency department or mobile coronary care unit. Those who fulfilled the following inclusion criteria were entered into the study:

1.	Typical ischaemic-type chest discomfort of ≥ 20minutes duration, occurring at rest and presentation within 12 hours of symptom onset;
2.	12L ECG performed at first medical contact;
3.	Informed consent to BSPM performed at first medical contact; and
4.	Blood sampled for cardiac troponin T (cTnT) at 12hrs from symptom onset. 

Patients were excluded from analysis if they had: any condition precluding assessment of the ST-segment, i.e. left bundle branch block, right bundle branch block, left ventricular hypertrophy, concomitant digitalis therapy or ventricular pacing; received fibrinolysis, nitrates or glycoprotein IIb/IIIa inhibitor prior to initial 12L ECG or BSPM; or BSPM recorded >15mins after initial 12L ECG. 






A 12L ECG was recorded at first medical contact (25mm/s and 10mm/mV). STE was measured at the J-point by a cardiologist who was blinded to all other clinical data. STE consistent with AMI (STEMI) was defined using the Minnesota code 9-2 [11] as ≥ 0.1mV STE in one or more of leads I, II, III, aVL, aVF, V5, V6 or ≥ 0.2mV STE in one or more of leads V1 – V4 [12, 13]. 

BSPM recording and analysis

The BSPM was recorded with a flexible plastic anterior and posterior electrode harness and a portable recording unit (Heartscape Technologies, Inc.). The anterior harness contains 64 electrodes, including 3 proximal bipolar limb leads (Mason-Likar position) and a posterior harness with 16 electrodes. This lead configuration enables recording of 77 unipolar ECG signals with respect to the Wilson central terminal. During the interpretation process the electrodes are defined to represent anterior, lateral, inferior, high right anterior, right ventricular and posterior epicardial regions [7]. Harness application takes 3 – 4 minutes. BSPMs were recorded over 5 – 10 seconds at a sampling rate of 1 kHz and a bandwidth of 0.05 – 100 Hz and transferred into digital format for core laboratory analysis. 






















Of the 48 patients studied (50% male; age 65 ± 16 yrs), results are shown in Table 1. Overall, no statistically significant differences were observed between male and female patients in any parameter. However, of those in Q1 (BMI ≤ 20.0 kg/m2 [n=12]), there were significant differences in both torso surface area and volume between male and female patients (p < 0.001). In addition, there were significant differences between circumferences in Planes 1-3 inclusive (p < 0.05) in this quartile. However, there were no significant differences between any measurements at any plane in either Q2 or Q3 (BMI 20.1 – 40.0 kg/m2). In Q4 (BMI > 40.0 kg/m2 [n=12]), all measurements showed no significant difference, except for both the coronal diameter in Plane 1 and the sagittal diameter in Plane 4 (p < 0.05).

Analysis of correlation revealed a strongly positive relationship, i.e. r2 > 0.500, between BMI and all parameters measured at Planes 1-5 inclusive (Figure 1). Furthermore, BMI positively correlated with torso volume, i.e. r2 = 0.855 (Figure 1). Based on these linear relationships, formulae (y = ax +b, where x = BMI) were derived with which to individualise the Dalhousie torso in order to achieve a patient-specific inverse solution. 

Phases 2 and 3





Overall, Minnesota code 9-2 STE was detected on initial 12L ECG in 132 (41%) patients (Table 3). Of these, 117 patients had AMI, i.e. cTnT ≥ 0.1µg/L (sensitivity 65%, specificity 89%). Overall, BSPM PRIME algorithm STE was detected in 160 (50%) patients, having sensitivity 81% and specificity 90% for AMI diagnosis (Table 3). Upon using a standard unadjusted Dalhousie torso for each patient, EPs derived by inverse electrocardiography improved both sensitivity and specificity for AMI diagnosis (Table 3). However, when the standard torso was individualised using BMI for each patient to derive EPs, sensitivity was further improved to 98% and a reduction in specificity was observed (79%).







Current guidelines recommend a door-to-balloon time of ≤ 90mins for STEMI patients undergoing primary PCI [13, 20] with multiple studies having demonstrated increasing morbidity and mortality with treatment delay in these patients [20]. Therefore, patients with acute coronary occlusion, i.e. STEMI, not detected by 12L ECG are more likely to undergo a delayed revascularisation strategy and are thus at increased risk of an adverse prognosis. To date, the 12L ECG remains the initial bedside investigation in the triage of patients presenting with acute ischaemic-type chest pain at rest despite its poor sensitivity for AMI diagnosis – a study has confirmed that the 12L ECG STE has only 50% sensitivity for AMI diagnosis using contrast-enhanced cardiac magnetic resonance imaging as a gold-standard [21]. In patients with Non-STE AMI, current guidelines suggest a maximum delay to invasive strategy of 72h from admission in those without high-risk clinical features, i.e. haemodynamic instability, malignant arrhythmia and/or refractory ischaemia [22]. In addition, the Occluded Artery Trial has shown no prognostic benefit of PCI for patients with an infarct artery that is occluded ≥24 hours after symptom onset [2]. It is therefore of utmost importance that stable patients with acute chest pain, an acutely occluded coronary artery and STE ‘missed’ by the standard 12L ECG are identified at the earliest possible time-point in order to facilitate emergent revascularisation and improve outcomes. 

BSPM has been shown to have sensitivity 76%, specificity 92% for AMI diagnosis in consecutive patients presenting with acute ischaemic-type chest pain at rest (n=755) [4]. Improvement in sensitivity over the 12L ECG (sensitivity 68%) has been shown to be mainly due to detection of STE in the high right anterior, posterior, and right ventricular territories [4]. In the OCCULT-MI trial, BSPM increased STEMI detection by 27.5% over the 12L ECG [6]. In this OCCULT-MI trial, STE on BSPM was associated with an increased risk of death and recurrent MI at 30-days (OR 3.4) in those without initial 12L ECG STEMI [6], due to a non-emergent revascularisation strategy.

Previous work from our centre has shown improvement in AMI detection by an epicardial algorithm using a standard torso in patients with a non-diagnostic 12L ECG [7]. Compared to other electrocardiographic techniques assessed, an epicardial algorithm correctly identified 53/83 patients with a non-diagnostic 12L ECG at presentation as AMI (sensitivity 64%, specificity 99%) - findings comparable to those presented in this study (41/63 patients; sensitivity 65%, specificity 94%). 

Furthermore, in the 427 patients with acute ischaemic-chest pain studied by Owens et al [7], the 12L ECG in combination with an epicardial algorithm (adjusted for confounders) derived EPs that had sensitivity 85% and specificity 98% for AMI diagnosis - using standard CK/CK-MB incremental elevation as the diagnostic standard [7]. Again, this is comparable to the results presented here, when a standard torso is used for the inverse calculation (sensitivity 88%, specificity 95%) [Table 3].





This is the first non-invasive study attempted in man to improve diagnosis of acute myocardial infarction using inverse electrocardiography (individual torso model) related to body habitus within the early hours of the onset of chest pain. Yes, there were limitations but the results are encouraging.
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Figure 1: Axial CT slice at Plane 3 (nipple level) with torso reconstruction and Planes 1-5 shown. Graphical plots of torso volume (top right) and CSA at Plane 3 (nipple level) [bottom right] against BMI, with both r2 values and linear equations shown.
BMI = body mass index; CSA = cross-sectional area; USN = upper sternal notch

Figure 2: 352-node Dalhousie torso

Figure 3: Case example
BMI = body mass index; BSPM = body surface potential map; cTnT = cardiac troponin-T; ECG = 12-lead electrocardiogram; EP = epicardial potentials; STE = ST-segment elevation.
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